MedTrace Logo

Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention

NCT06347367 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-05-29

No results posted yet for this study

Summary

Abdominal bloating and distension (ABD) are the most commonly gastrointestinal symptoms reported by patients with various functional gut disorders such as functional dyspepsia, irritable bowel syndrome and it is frequently associated with constipation. The pathophysiology of ABD is complex, often multifactorial and poorly understood. The reseach was hypothesised that short-term self-manual approaches and exercise for core muscles would have a positive effect on the symptoms of ABD.

Conditions

  • Gastrointestinal System Disease
  • Functional Bloating
  • Distension; Bowel
  • Gastrointestinal Motility Disorder
  • Pelvic Floor Dyssynergia

Interventions

OTHER

Group 1 (exercise and self-manual approaches targeting only the diaphragm muscles)

Both groups will receive the patient education before treatment. Diaphragmatic stretching technique, pectoral muscle relaxation, diaphragmatic mobilisation, thoracic mobilisation and diaphragmatic breathing. Exercise and self-manual approaches will be performed at home 3 times a day for 8 repetitions for 4 weeks and approximately 45-60 minutes.

OTHER

Group 2 (exercise and self-manual approaches targeting both diaphragm and core muscles)

İn addition to Group 1, patients in group 2 will receive, abdominal massage, abdominal mobilisation, stabilisation exercises and pelvic floor muscle training. Exercise and self-manual approaches will be performed at home 3 times a day for 8 repetitions for 4 weeks and approximately 45-60 minutes.

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Nuray ELİBOL · Ege University

  • Gülruh KARABAĞLI · Ege University

  • Melahat AKTAŞ · Dokuz Eylul University

  • Özge ÇELİKER TOSUN · Dokuz Eylul University

  • Serhat BOR · Ege University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-06-17
Completion
2024-06-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06347367 on ClinicalTrials.gov